VOCEMIVY
PendingWord Mark
Never miss important updates for VOCEMIVY
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
VP
Owner Name
Type: Organization / Corporation
Address
Address not available
Critical Dates
First Use Date
Not filed yet
Filing Date
Feb 6, 2025
Publication Date
Oct 7, 2025
Mark Descriptions
Goods
Class 5
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease
Mark Elements
Text Mark
VOCEMIVY
Category
Trademark
Standard Characters
No
Color Claim
No
Trademark Timeline
Filing Date
Publication Date
USPTO Records
No documents found for this trademark.